FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082040 [Registered on: 10/03/2025] Trial Registered Prospectively
Last Modified On: 07/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Mobile application ]  
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Mobile application for Rehabilitation of Patients with Stroke  
Scientific Title of Study   Novel app for Rehabilitation of Patients with Cerebrovascular Accidents and Comparison of the Incidence of Complications in Patients using the application and Patients on Conventional Follow up  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vijay yaswanth reddy bade  
Designation  Post Graduate, general medicine  
Affiliation  Saveetha Medical College Hospital 
Address  Room no:01, Department of General Medicine,Saveetha Medical College and Hospital ,Saveetha Nagar, Thandalam, Chennai , TAMIL NADU

Kancheepuram
TAMIL NADU
602105
India 
Phone  8686862552  
Fax    
Email  iamvjbade@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR GUNASEKARAN 
Designation  Professor, General Medicine 
Affiliation  Saveetha Medical College Hospital 
Address  Room no:01, Department of General Medicine,Saveetha Medical College and Hospital ,Saveetha Nagar, Thandalam, Chennai , TAMIL NADU

Kancheepuram
TAMIL NADU
602105
India 
Phone  9884398420  
Fax    
Email  drguna59@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR GUNASEKARAN 
Designation  Professor, General Medicine 
Affiliation  Saveetha Medical College Hospital 
Address  Room no:01, Department of General Medicine,Saveetha Medical College and Hospital ,Saveetha Nagar, Thandalam, Chennai , TAMIL NADU


TAMIL NADU
602105
India 
Phone  9884398420  
Fax    
Email  drguna59@gmail.com  
 
Source of Monetary or Material Support  
Saveetha Medical College and Hospital, Saveetha Nagar, Thandalam, Chennai- 602105 
 
Primary Sponsor  
Name  Saveetha Medical College and Hospital  
Address  Saveetha Nagar, Thandalam, Chennai, Tamil Nadu 602105 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vijay yaswanth reddy bade   Saveetha medical college and hospital  Room number -01,Department of General Medicine ,Saveetha nagar,Thandalam kancheepuram district,chennai-602105
Kancheepuram
TAMIL NADU 
8686862552

iamvjbade@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Saveetha medical college and hospital Institutional Ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G968||Other specified disorders of central nervous system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Application for rehabilitation of patients with cerebrovascular accidents   Application based rehabilitation and care of patients with cerebrovascular accidents for 3 month duration 
Comparator Agent  Conventional rehabilitation for Cerebrovascular Accidents  Conventional rehabilitation for Cerebrovascular patients with Drugs, Physiotherapy and other Supportive management for 3 month duration 
 
Inclusion Criteria  
Age From  45.00 Year(s)
Age To  85.00 Year(s)
Gender  Both 
Details  1.Patients undergoing rehabilitation at the specified healthcare facility.
2.Patients with the ability to provide informed consent or with a legally authorized representative available to provide consent on their behalf.
 
 
ExclusionCriteria 
Details  1.Age: Participants under the age of 45 years.
2.Patients with pre-existing conditions or comorbidities that significantly impact rehabilitation outcomes or ability to participate in the study.
3.Patients with a history of substance abuse or psychiatric disorders that may interfere with study participation or compliance with the intervention.
4.Patients with a history of previous strokes or neurological conditions unrelated to the current cerebrovascular accident.
5.Patients with unstable medical conditions or recent surgeries that may affect their ability to participate in the study or adhere to the intervention protocols 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in Physical Function (Physiotherapy Outcomes):
Measure: Change in physical function as assessed by standardized scales like the Modified Rankin Scale (mRS), Barthel Index . 
At baseline and three months  
 
Secondary Outcome  
Outcome  TimePoints 
1. Reduction in Complications,
2. Quality of Life (QoL) scale
3. Incidence of Additional Medical Complications and secondary stroke
 
At baseline and three months  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   20/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The proposed project focuses on the development and evaluation of a novel mobile application for the rehabilitation of patients who have experienced cerebrovascular accidents (CVAs), commonly known as strokes. The study aims to compare the effectiveness of this application with conventional follow-up methods in improving patient outcomes and reducing the incidence of complications.

Cerebrovascular accidents are a significant cause of disability and mortality worldwide, often resulting in impairments in motor function, cognition, and activities of daily living. Traditional rehabilitation approaches involve physical therapy, occupational therapy, and speech therapy, tailored to individual patient needs. However, these methods may have limitations in terms of accessibility, adherence, and monitoring of progress.

With advancements in technology, mobile applications offer a promising platform for delivering personalized rehabilitation interventions. The novel application developed for this study provides interactive exercises, cognitive training, and real-time progress tracking, aiming to enhance the rehabilitation process for CVA patients.

The research involves a randomized controlled trial, where patients are divided into two groups: one utilizing the rehabilitation application alongside standard care, and the other receiving conventional follow-up treatment. Key outcomes measured include functional improvement, quality of life, and the occurrence of complications such as secondary strokes, infections, and functional decline.

Preliminary findings suggest potential benefits of the rehabilitation application in reducing complication incidence and improving rehabilitation outcomes. However, further analysis with a larger sample size and longer follow-up duration is needed to validate these results.

Overall, this study contributes to the growing body of knowledge in stroke rehabilitation and healthcare technology, offering insights into the role of mobile applications in optimizing outcomes and improving the quality of care for CVA patients.


 
Close